NCT02264067View on ClinicalTrials.gov

Pharmacokinetics and Safety of WAL2014 (Talsaclidine) in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

November 30, 1998

Conditions
Healthy
Interventions
DRUG

Talsaclidine

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY